Hovis Gabrielle E A, Pandey Aryan, Chandla Anubhav, Casaos Joshua, Yang Isaac
Departments of1Neurosurgery.
2Radiation Oncology, and.
J Neurosurg. 2024 Nov 15;142(4):1149-1162. doi: 10.3171/2024.6.JNS24680. Print 2025 Apr 1.
Hearing outcomes following Gamma Knife radiosurgery (GKRS) for vestibular schwannoma (VS) are multifactorial and poorly characterized in prior literature. In this study the authors evaluated hearing outcomes chronologically to identify prognostic factors of serviceable hearing preservation (HP) rates following GKRS for VS.
Six medical databases were queried according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Eligible studies reported VS treated with single-fraction GKRS and included the HP rate following GKRS. HP was defined as a postoperative Gardner-Robertson score ≤ 2 among patients with preoperative serviceable hearing. A meta-analysis with random-effects modeling was performed for variables of interest.
Data from 42 articles with a total of 6582 patients were analyzed; the average age of patients was 54 years and the average follow-up time was 68 months. The pooled proportion of preoperative serviceable hearing was 76%, and the pooled HP rate was 60% at the last follow-up visit. At < 5 years after GKRS, age was significantly correlated with HP on both continuous and categorical analyses (p = 0.001 and p = 0.011, respectively). Between 5 and < 10 years of follow-up, HP was associated with a radiation dose of 12.5 Gy, but not with age or tumor volume. At ≥ 10 years after radiosurgery, a significant negative correlation was seen between marginal radiation dose and HP on both continuous and categorical analyses (p = 0.001 and p = 0.021, respectively).
This meta-analysis identifies age and radiation dose as independent prognostic factors for HP. Age-related hearing deterioration appears to be concentrated in the first 5 years after GKRS, whereas radiation dose was associated with HP at last follow-up, between 5 and < 10 years, and at ≥ 10 years after radiosurgery. This meta-analysis offers an objective overview of the literature and a framework for clinical decision-making, with applications for treatment planning and patient counseling.
伽玛刀放射外科手术(GKRS)治疗前庭神经鞘瘤(VS)后的听力结果受多种因素影响,既往文献对此描述不足。在本研究中,作者按时间顺序评估听力结果,以确定GKRS治疗VS后可保留有用听力(HP)率的预后因素。
根据系统评价和Meta分析的首选报告项目(PRISMA)指南查询六个医学数据库。符合条件的研究报告了单剂量GKRS治疗的VS,并包括GKRS后的HP率。HP定义为术前有有用听力的患者术后Gardner-Robertson评分≤2。对感兴趣的变量进行随机效应模型的Meta分析。
分析了42篇文章中的数据,共6582例患者;患者平均年龄为54岁,平均随访时间为68个月。术前有有用听力的患者合并比例为76%,最后一次随访时合并HP率为60%。在GKRS后<5年,年龄在连续分析和分类分析中均与HP显著相关(分别为p = 0.001和p = 0.011)。在随访5至<10年之间,HP与12.5 Gy的放射剂量相关,但与年龄或肿瘤体积无关。在放射外科手术后≥10年,边缘放射剂量与HP在连续分析和分类分析中均呈显著负相关(分别为p = 0.001和p = 0.021)。
这项Meta分析确定年龄和放射剂量是HP的独立预后因素。与年龄相关的听力恶化似乎集中在GKRS后的前5年,而放射剂量与最后一次随访时、随访5至<10年以及放射外科手术后≥10年的HP相关。这项Meta分析提供了文献的客观概述和临床决策框架,可应用于治疗计划和患者咨询。